NFKB1 and acute lymphoblastic leukemia: Interestingly, the specific cross-talk between NF-κB and Notch1 was recently highlighted using GSIs, with in vitro pharmacological Notch inhibition leading to a dose-dependent reduction in NF-κB transcriptional activity in HRS cells, as also observed in T-ALL [96].